Updates - COVID-19
The number of people infected with the SARS-CoV-2 coronavirus in the Netherlands rose on Saturday for the fifth day in a row. The Dutch public health agency, RIVM, announced on Saturday that an additional 1,146 people tested positive. That is the largest single-day total since June 12.
The Dutch Ministry of Foreign Affairs has issued a Code Orange travel alert for eight countries on Tuesday. Travelers entering the Netherlands from Belgium, France, Ireland and the United Kingdom will be told to enter quarantine for ten days upon arrival.
A requirement to wear face masks was not one of the new social restrictions introduced by the national government on Monday night to combat the coronavirus crisis, but residents of the regions around Amsterdam, Rotterdam, The Hague, and Eindhoven were urgently advised to wear a face mask whenever in an indoor space accessible to the public. Amsterdam Mayor Femke Halsema, who also serves as the chair of the Amsterdam-Amstelland Security Region, made the announcement at a press conference shortly after Prime Minister Mark Rutte wrapped up his own.
pJakarta (ANTARA) - Director General of Financing and Risk Management of the Finance Ministry Luky Alfriman drew special attention to the three major focus areas of the government's agenda to address the impacts of the COVID-19 pandemic.
Bandung (ANTARA) - Uji klinis fase tiga vaksin COVID-19 Sinovac, China, secara resmi dimulai di Indonesia, Selasa (11/8) yang ditandai dengan peninjauan fasilitas dan kapasitas produksi di Bio Farma serta penyuntikan perdana Relawan Uji Klinis Vaksin COVID-19 di Fakultas Kedokteran Unpad Kota Bandung, Jawa Barat, yang disaksikan oleh Presiden RI Joko Widodo.
Jakarta (ANTARA) - Indonesia is working with South Korea to develop a vaccine for the novel coronavirus disease, in addition to collaborating with China.
Jakarta (ANTARA) - The expert team of the COVID-19 Disease Response Acceleration Task Force is eyeing to test 30 thousand specimens daily for the diagnosis of coronavirus infections.
